CEO-TWO
- Product NDC
- 0283-1023
- 11-digit product format
- 002831023
- Labeler code
- 0283
- Product ID
- 0283-1023_42e0774e-b617-290d-e063-6394a90a199e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Laxative
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Beutlich Pharmaceuticals, LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-10-15
- Substance
- POTASSIUM BITARTRATE; SODIUM BICARBONATE
- Active strength
- .9; .6 g/5.7g; g/5.7g
- Pharmacologic classes
- Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEO-TWO
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM BITARTRATE | .9 g/5.7g |
| SODIUM BICARBONATE | .6 g/5.7g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NPT6P8P3UU | Internal UNII lookup |
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08670636-5795-4db0-e063-6294a90afa4b | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0283-1023-00 | CEO-TWO | 5.7 g in 1 DOSE PACK | SUPPOSITORY | 5.7 | 3 | |
| 0283-1023-02 | CEO-TWO | 2 in 1 BOX | SUPPOSITORY | 2 | 3 | |
| 0283-1023-36 | CEO-TWO | 6 in 1 BOX | SUPPOSITORY | 6 | 3 | |
| 0283-1023-54 | CEO-TWO | 54 in 1 BOX | SUPPOSITORY | 54 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0283-1023-02 | EA - Each | 0283-1023 | d7803fbb-22f6-4acb-bdd2-b3da0cb16667 | 1 | 2025-08-11 |
| 0283-1023-36 | EA - Each | 0283-1023 | 299afce1-70d3-4bcd-88c0-094182298613 | 1 | 2025-08-11 |
| 0283-1023-54 | EA - Each | 0283-1023 | aab567b9-183d-4296-a18e-a6c0a9c6cd3e | 1 | 2025-08-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener plus Stimulant Laxative | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | CARDINAL HEALTH, 110 DBA LEADER | 3fd9ba76-42f8-4ebe-b1bc-f81f08e702ce | 2026-03-06 | Warnings | M007 |
| Magnesium Citrate | EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON | Walmart Inc. | 484d0421-59ea-3783-e063-6394a90af633 | 2026-03-04 | Warnings | M007 |
| Magnesium Citrate | EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | Walmart Inc. | 484c2586-9e6f-1ce5-e063-6394a90a0d81 | 2026-03-04 | Warnings | M007 |
| Magnesium Citrate | EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | Walmart Inc. | 450ddcbd-7ccd-3670-e063-6294a90ac2bd | 2026-03-04 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Amazon.com Services LLC | 787ec4b0-c6c5-44ab-a53d-d6d25304f95e | 2026-03-03 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 3d0d63d7-640d-4e54-a6fd-6b265c79be09 | 2026-03-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-03-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-03-02 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Old East Main Co. | a8af6e2d-0052-4fc9-a51a-c9dbeb1ad3f5 | 2026-03-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Chain Drug Marketing Association | 629c5817-13b7-4527-8998-93131ee3529e | 2026-02-27 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Chain Drug Marketing Association | 4df97cdc-e7a2-4350-8f95-a679cdcaff64 | 2026-02-27 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Chain Drug Marketing Association | 46b26b44-e065-4337-a071-fa036f897140 | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | Chain Drug Marketing Association | ef163b24-ce92-4cbc-b45a-4fae3b511949 | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Chain Drug Marketing Association | 4ee26633-8eb1-4c68-a768-20460404533a | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Mineral Oil | MINERAL OIL | Chain Drug Marketing Association | 3bfdad9c-ac58-4e92-b952-555e8a8351cd | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | The Kroger Co. | 2bcab227-42b6-4bff-8363-f6800665755b | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | The Kroger Co. | a87dceb2-da73-4d3a-b87c-db2af10471bf | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Sunscreen | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | The Kroger Co. | 3ae7e275-7bbc-4e62-b30f-013c40a89949 | 2026-02-27 | Warnings | M007 |
| Sennosides | SENNOSIDES | CVS Pharmacy, Inc | 0b7736df-c7de-7d00-e063-6294a90aa57e | 2026-02-26 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 5d300ea7-78eb-4e19-8333-1e42c73c4c54 | 2026-02-26 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 636188 | CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository [Ceo-Two] | SBD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository | SCD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0283-1023-00 | 00283102300 | 5.7 g in 1 DOSE PACK | 5.7 g | Historical | |||
| 0283-1023-02 | 00283102302 | 2 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 2 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-36 | 00283102336 | 6 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 6 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-54 | 00283102354 | 54 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 54 dose pack | 2023-10-15 | No | No | Current |